Obinutuzumab (GA101): exhibits enhanced cell death and ADCC compared to Rituximab in RTX resistant and sensitive cell lines against B-cell non-Hodgkin lymphomaA. Awasthi,J. Ayello,C. Van de Ven,D. Glassman, A. Sabulski,M. J. Barth,M. S. CairoBRITISH JOURNAL OF HAEMATOLOGY（2012）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
